[go: up one dir, main page]

MX2019004393A - Composicion farmaceutica que comprende drospirenona y kit anticonceptivo. - Google Patents

Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.

Info

Publication number
MX2019004393A
MX2019004393A MX2019004393A MX2019004393A MX2019004393A MX 2019004393 A MX2019004393 A MX 2019004393A MX 2019004393 A MX2019004393 A MX 2019004393A MX 2019004393 A MX2019004393 A MX 2019004393A MX 2019004393 A MX2019004393 A MX 2019004393A
Authority
MX
Mexico
Prior art keywords
drospirenone
pharmaceutical composition
contraceptive kit
present
contraceptive
Prior art date
Application number
MX2019004393A
Other languages
English (en)
Inventor
Velada Jose
Drouin Dominique
Perrin Philippe
Original Assignee
Laboratorios Leon Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48802149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2019004393(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Leon Farma Sa filed Critical Laboratorios Leon Farma Sa
Publication of MX2019004393A publication Critical patent/MX2019004393A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere al campo de las composiciones farmacéuticas y métodos anticonceptivos. La presente invención proporciona una composición farmacéutica que comprende drospirenona caracterizada por un intervalo de disolución lento de drospirenona in vitro y un perfil farmacocinético y mejorado. El uso de este compuesto en métodos anticonceptivos y kits también es proporcionado.
MX2019004393A 2010-06-29 2012-12-13 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo. MX2019004393A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10305708 2010-06-29
US36839610P 2010-07-28 2010-07-28

Publications (1)

Publication Number Publication Date
MX2019004393A true MX2019004393A (es) 2019-09-09

Family

ID=48802149

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2015008884A MX364971B (es) 2010-06-29 2011-06-28 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.
MX2012014629A MX339952B (es) 2010-06-29 2011-06-28 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.
MX2019004393A MX2019004393A (es) 2010-06-29 2012-12-13 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2015008884A MX364971B (es) 2010-06-29 2011-06-28 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.
MX2012014629A MX339952B (es) 2010-06-29 2011-06-28 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.

Country Status (14)

Country Link
KR (1) KR102210982B1 (es)
BR (1) BR122019008317A2 (es)
CL (1) CL2012003685A1 (es)
CO (1) CO6640328A2 (es)
DK (1) DK2588114T3 (es)
EC (3) ECSP12012359A (es)
ES (1) ES2777886T3 (es)
GT (3) GT201200336AA (es)
HR (1) HRP20200155T1 (es)
HU (1) HUE047689T2 (es)
LT (2) LT2588114T (es)
MX (3) MX364971B (es)
PT (1) PT2588114T (es)
ZA (1) ZA201209743B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250129555A (ko) 2024-02-22 2025-08-29 단국대학교 천안캠퍼스 산학협력단 드로스피레논을 유효성분으로 포함하는 신경 질환 예방 또는 치료용 약학 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone

Also Published As

Publication number Publication date
HUE047689T2 (hu) 2020-05-28
GT201200336A (es) 2014-01-14
HRP20200155T1 (hr) 2020-05-01
ECSP15032911A (es) 2016-01-29
LTPA2021523I1 (es) 2021-11-10
GT201200336AA (es) 2017-10-23
ECSP15032906A (es) 2016-01-29
GT201200336BA (es) 2017-10-23
MX364971B (es) 2019-05-16
CO6640328A2 (es) 2013-03-22
DK2588114T3 (da) 2020-02-17
ZA201209743B (en) 2014-03-26
CL2012003685A1 (es) 2013-07-05
MX339952B (es) 2016-06-20
KR102210982B1 (ko) 2021-02-02
PT2588114T (pt) 2020-02-20
MX2012014629A (es) 2013-05-06
LT2588114T (lt) 2020-02-25
ES2777886T3 (es) 2020-08-06
BR122019008317A2 (pt) 2020-09-29
KR20190073598A (ko) 2019-06-26
ECSP12012359A (es) 2013-03-28

Similar Documents

Publication Publication Date Title
PH12012502499A1 (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
MX2012000396A (es) Metodos y composiciones para uso en tartamientos celulares.
IL222738A0 (en) Pharmaceutical emulsion composition comprising progestogen
TN2011000656A1 (en) Pharmaceutical composition for emergency contraception
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
MX2019000225A (es) Composiciones y metodos para el tratamiento de enfermedades autoinmunes y otras enfermedades.
IL214822A0 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
ZA201100605B (en) Micronised progesterone pharmaceutical composition and uses thereof
MX2013001677A (es) Formulaciones estables de linaclotida.
PH12013500500A1 (en) Fused heteroaryls and their uses
MX2013004981A (es) Composiciones y metodos para la administracion de agentes terapeuticos.
ZA201403431B (en) Pharmaceutical compositions and methods of use of 4-pregenen-11b-21-triol-3,20-dione derivatives
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
PH12014500714A1 (en) Stable sns-595 compositions and methods of preparation
MX2019004393A (es) Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.
EP2568810A4 (en) COMPOSITIONS OF DARUNAVIR
GB201405031D0 (en) Storage stable premixed hydraulic cement compositions, cements, methods, and articles
ZA201105443B (en) Novel saponin compounds,methods of preparation thereof,use thereof and pharmaceutical compositions
UA59396U (ru) Применение композиций нестероидных противовоспалительных средств с кофеином как препаратов с антиэкссудативной активностью